In 2017, not only did Dr. Christian Kratz launch our international chapter, LFSA – Germany, but he also founded the German Cancer Predisposition Syndrome Registry based at Hannover Medical School, Hannover, Germany. The registry collects information on genotypes, personal medical details, family histories, and surveillance, as well as a range of biospecimens. In today’s publication
Dana-Farber Cancer Institute is ISO youths and young adults (age 12-24) to assist in a social study of those who have a childhood onset hereditary cancer syndrome or who have a first degree relative with a hereditary cancer syndrome and have tested negative themselves. Please reference here for more information: DFCI psychosocial research flyer
Dr. Kara N. Maxwell, assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania, is the lead author of the study published December 2021 in the European Urology, “Inherited TP53 Variants and Risk of Prostate Cancer.” The team of American researchers concluded that men who inherit mutations in a gene
“Cancer incidence, patterns, and genotype–phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study” (November 2021). Authored by a strong team of LFS experts that includes members of the LFSA’s Medical Advisory Board and Genetic Counseling Advisory Group is the most recent review of LFS published by The Lancet.
HOLLISTON, MA -- The Li-Fraumeni Syndrome Association (LFSA), dedicated to furthering research and worldwide awareness of the inherited cancer predisposition disorder, celebrates new findings published in the renowned JAMA Oncology journal with implications to better predict cancer risk. First presented at LFSA's 5th International Symposium last year, the concept of analyzing tumor patterns and genetic
The LFS Association’s Genetic Counselor Advisory Group has produced yet another wonderful resource – a booklet explaining LFS that is geared towards 8 – 13 year old children. This booklet supports information about Li-Fraumeni syndrome (LFS) that you and the health care team have shared with your child.
Dear LFS Patient and Provider Community, The Li-Fraumeni Syndrome Association’s (LFSA) board of directors and its medical advisors have determined there is sufﬁcient evidence to recommend that in addition to regular physical exams and other investigations, that all patients diagnosed with Li-Fraumeni syndrome (LFS) receive annual rapid whole-body MRI imaging (WBMRI). The LFSA is in
With the help of the LFSA Genetic Counseling Advisory Group, the LFSA is proud to announce the new Li-Fraumeni syndrome FAQ sheet. Take a moment to read or share the FAQs with family, friends and care providers. If you have a suggestion or a topic you would like included, please contact us at email@example.com.